SCHULHOFF & CO INC SPRY — ARS PHARMACEUTICALS

Ownership history in SCHULHOFF & CO INC  ·  5 quarters on record

AI Ownership Summary

SCHULHOFF & CO INC reported ARS PHARMACEUTICALS (SPRY) in 5 quarterly 13F filings from 2025 Q1 through 2026 Q1. Peak portfolio weight reached 0.34% in 2025 Q2. The latest visible filing shows SPRY at 0.17% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this SPRY ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SCHULHOFF & CO INC's position in ARS PHARMACEUTICALS, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

SPRY was reported at 0.17% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.34% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

SPRY stock page SCHULHOFF & CO INC fund profile SCHULHOFF & CO INC full holdings
How SCHULHOFF & CO INC held SPRY — position size vs. price
% of Fund (quarterly)    SPRY price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 51,150 — 0% 0.17% $411K 2026-05-11 $8.60
2025 Q4 ADDED — — — 51,150 +7,650 +17.6% 0.25% $596K 2026-02-11 $9.50
2025 Q3 UNCHANGED — — — 43,500 — 0% 0.19% $437K 2025-11-10 $8.88
2025 Q2 ADDED — — — 43,500 +3,000 +7.4% 0.34% $759K 2025-07-30 $17.88
2025 Q1 INITIATED — — — 40,500 — — 0.23% $509K 2025-05-07 $13.49

🏢 Other funds also holding SPRY

As of 2026 Q1 — sorted by position size

INVESTMENT MANAGEMENT ASSOCIATES INC /ADV 3Y 0.69% AMERICAN ASSETS INC 3Y 7Y 0.57% Tejara Capital Ltd 3Y 0.56% GENERAL AMERICAN INVESTORS CO INC 3Y 7Y 0.38% Empire Life Investments Inc. 3Y 7Y 0.25% Matisse Capital 3Y 7Y 0.23% VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 3Y 0.2% CenterBook Partners LP 3Y 0.13% Tannin Capital LLC 0.11% Norman Fields, Gottscho Capital Management, LLC 3Y 7Y 0.11%

FAQ About SCHULHOFF & CO INC and SPRY

These are the practical questions this page is built to answer before you even open the full history table.

How long has SCHULHOFF & CO INC reported owning SPRY?

SCHULHOFF & CO INC reported SPRY across 5 quarterly 13F filings, from 2025 Q1 through 2026 Q1.

What was the largest reported SPRY position in SCHULHOFF & CO INC's portfolio?

The largest reported portfolio weight for SPRY was 0.34% in 2025 Q2.

What is the latest reported SPRY position on this page?

The most recent filing on this page is 2026 Q1, when SCHULHOFF & CO INC reported 51,150 shares, equal to 0.17% of portfolio, with an estimated market value of $411K.

What does the chart on this SPRY ownership page compare?

The chart compares SCHULHOFF & CO INC's quarterly SPRY portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SCHULHOFF & CO INC time their SPRY position?

Based on 13F filing dates vs. subsequent SPRY price moves, SCHULHOFF & CO INC correctly timed 1 out of 3 reported position changes (33%). The annualised alpha on SPRY relative to SPY over the holding period was -51.8%.

← Back to SCHULHOFF & CO INC Holdings